You just decided to invest a significant portion of your innovation budget to power your clinical trial with new mobile health technology. Now what?
Mobile health (mHealth) rewires the way clinical trials are done.
Throughout the duration of a study, researchers must frequently monitor clinical trial participants’ responses to a drug and capture precise sets of measurements. Utilizing digital health devices in remote patient monitoring can streamline the process, and enable the seamless collection of key biometric and activity data.
Last year brought us Apple's ResearchKit, setting a new benchmark for how mobile devices fit into clinical research.
Next week, I’ll be teaming up with Drew Schiller, one of the co-founders of digital health platform Validic, in a webchat about using digital health tools to make solid progress in drug development.
Pharma's sentiment that the federal government’s policies perpetually lag behind innovations pioneered by the private sector has resulted in a vicious cycle of stagnated progress.
Pharma is due for disruption and tech seems ready to deliver it.